Global Oral Clinical Nutritional Supplements Market Insights and Forecast to 2028

Oral clinical nutritional supplements are sterile liquids, semi-solids or powders, which provide macro and micro nutrients.
Market Analysis and Insights: Global Oral Clinical Nutritional Supplements Market
Due to the COVID-19 pandemic, the global Oral Clinical Nutritional Supplements market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Liquid Supplements accounting for % of the Oral Clinical Nutritional Supplements global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Paediatric segment is altered to an % CAGR throughout this forecast period.
China Oral Clinical Nutritional Supplements market size is valued at US$ million in 2021, while the US and Europe Oral Clinical Nutritional Supplements are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oral Clinical Nutritional Supplements landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Oral Clinical Nutritional Supplements include Medline Industries, Baxter, B. Braun Melsungen, Fresenius Kabi, Otsuka Pharmaceutical, Abbott Laboratories, Nutricia, GlaxoSmithKline and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Oral Clinical Nutritional Supplements Scope and Segment
Oral Clinical Nutritional Supplements market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oral Clinical Nutritional Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Liquid Supplements
Semi-Solid Supplements
Powder Supplements
Segment by Application
Paediatric
Adult
Geriatric
By Company
Medline Industries
Baxter
B. Braun Melsungen
Fresenius Kabi
Otsuka Pharmaceutical
Abbott Laboratories
Nutricia
GlaxoSmithKline
Pfizer
Perrigo
Nature’s Bounty
Sichuan Kelun Pharmaceutical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E